Michael W. Becker, M.D.

Michael W. Becker, M.D.

Contact Information

University of Rochester Medical Center
School of Medicine and Dentistry
601 Elmwood Ave, Box 704
Rochester, NY 14642

Administrative: (585) 275-4099
Fax: (585) 276-2596

Research Bio

The Becker lab studies malignant stem cell populations in myeloid neoplasms. By combining the power of cell sorting, qPCR based gene expression analysis and advanced normal and cancer stem cell models, we are now able to characterize the contribution of normal somatic tissue stem cells to the development of cancers, including Acute Myelogenous Leukemia and MDS. Our lab uses model systems and gene expression analysis to compare normal stem cells with their malignant counterparts with the goal of an improved understanding of the origins of cancer stem cells and to identify novel targets for therapy.

We have employed a unique flow cytometry platform and analysis approach to differentiate normal and malignant stem cell and progenitor populations in patients undergoing treatment for AML and MDS. This platform allows us to assess the impact of therapy on malignant stem cell populations and their gene signatures in patients undergoing treatment of their disease. In addition, we are interested in the role of the microenvironment in supporting malignant stem cell populations.

Awards & Honors (Local)

Internal Medicine Research Award | University of Michigan | Ann Arbor, Michigan 1999
AOA (Junior class initiate) 1995


Modulation of CCL3 Expression to Accelerate Hematopoietic Recovery in the Setting of Myeloid Leukemia

United States Serial NO.: 14/194,344
Filed Date: February 28, 2014
Title: Compositions and Methods for Inhibiting CCL3
Invented by: Benjamin Frisch, Laura Calvi, Michael Becker

Recent Journal Articles

Showing the 5 most recent journal articles. 33 available »

2013 Nov 22
Pei S, Minhajuddin M, Callahan KP, Balys M, Ashton JM, Neering SJ, Lagadinou ED, Corbett C, Ye H, Liesveld JL, O'Dwyer KM, Li Z, Shi L, Greninger P, Settleman J, Benes C, Hagen FK, Munger J, Crooks PA, Becker MW, Jordan CT. "Targeting aberrant glutathione metabolism to eradicate human acute myelogenous leukemia cells." The Journal of biological chemistry. 2013 Nov 22; 288(47):33542-58. Epub 2013 Oct 02.
2013 Nov 1
Ho TC, Becker MW. "Defining patient-specific risk in acute myeloid leukemia." Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2013 Nov 1; 31(31):3857-9. Epub 2013 Sep 23.
2013 Sep
Sen S, Hassane DC, Corbett C, Becker MW, Jordan CT, Guzman ML. "Novel mTOR inhibitory activity of ciclopirox enhances parthenolide antileukemia activity." Experimental hematology. 2013 Sep; 41(9):799-807.e4. Epub 2013 May 06.
2013 Sep
Hashmi S, Oliva JL, Liesveld JL, Phillips GL, Milner L, Becker MW. "The hematopoietic cell transplantation specific comorbidity index and survival after extracorporeal photopheresis, pentostatin, and reduced dose total body irradiation conditioning prior to allogeneic stem cell transplantation." Leukemia research. 2013 Sep; 37(9):1052-6. Epub 2013 Jul 03.
2013 May
Liesveld J, Pawlowski J, Chen R, Hyrien O, Debolt J, Becker M, Phillips G, Chen Y. "Clinical factors affecting engraftment and transfusion needs in SCT: a single-center retrospective analysis." Bone marrow transplantation. 2013 May; 48(5):691-7. Epub 2012 Oct 22.

Current Appointments

Associate Professor - Department of Medicine, Hematology/Oncology (SMD) - Primary
Associate Professor - Cancer Center


Internal Medicine - American Board of Internal Medicine
Medical Oncology - American Board of Internal Medicine


MD | Medicine | Univ Cincinnati Coll Medicine1996
MS | Chemistry | Univ of Cincinnati1991
BS | Chemistry | Univ of Cincinnati1988

Post-Doctoral Training & Residency

Fellowship in Oncology at University of Michigan Medical Center07/01/1999 - 06/30/2002
Residency in Internal Medicine at University of Michigan Medical Center07/01/1997 - 06/30/1999
Internship in Internal Medicine at University of Michigan Medical Center06/24/1996 - 06/23/1997